FDA Issues Warning To Baby Formula Manufacturers
Three manufacturers have issued recalls since December
The Food and Drug Administration (FDA) issued warning letters to three baby formula manufacturers, the agency said Wednesday.
ByHeart Inc, Mead Johnson Nutrition (Reckitt), and Perrigo Wisconsin, LLC, each issued recalls in December 2022, February 2023 and March 2023, respectively, in response to their products potentially containing the bacteria Cronobacter sakazakii.
It is the same bacteria that was found to contaminate Abbott Labs baby formula products manufactured at its Sturgis, Michigan, plant in early 2022. This contamination was linked to at least two infant deaths, and the eventual shut down of the facility triggered a devastating shortage of baby formula that carried into this year.
The bacteria thrives in very dry places, like the inside of a baby formula canister.
The FDA is not currently telling consumers to dispose of any baby formula they purchased from the manufacturers it warned this week, and the agency does not believe that any formula on the market is currently contaminated.
“The FDA is issuing these letters now as part of its normal regulatory process and to reinforce to these firms the importance of instituting and maintaining appropriate corrective actions when they detect pathogens to ensure compliance with the FDA’s laws and regulations,” the statement says.
The companies will need to conduct investigations to determine the cause of the contaminants that prompted recalls, and reevaluate their sanitation protocols before releasing more products onto the market. They will have 15 working days to inform the FDA of what measures they are taking to improve conditions. Regulators will assess whether their actions are sufficient when they next inspect the facilities.
- Nutramigen Baby Formula Recalled Over Possible Bacterial Contamination
- Empty shelves and hungry kids: The U.S. baby formula shortage is a crisis
- Recalled Gerber Baby Formula Still Shipped to Retailers After Notice
- FTC Investigating Whether Baby-Formula Makers Colluded: Report
- ‘Quality Issues’ in Chinese-Manufactured Syringes Could Lead to Problems With Medicine, FDA Warns
- FDA Issues Warning After Infant Dies From Probiotic
“The FDA is committed to identifying and acting on issues early to prevent any firms from reaching the level of concern that prompted last year’s large-scale recall and contributed to the infant formula shortage,” said Donald Prater, acting director of the FDA’s Center for Food Safety and Applied Nutrition, in the statement. “These letters are a reflection of this enhanced oversight.”
- The Top Wellness Trends in Sleep, Food and MoreHealth
- Michael Bolton Recovering From Brain Tumor Removal, Taking ‘Temporary Break’Entertainment
- Measles Outbreak Linked to Iconic Children’s HospitalHealth
- Toxic Yellow Oleander Found in Some Weight Loss Supplements, FDA WarnsHealth
- Goop’s New Year’s ‘Detox’ Is as Restrictive as You’d ThinkHealth
- Florida’s Bid for Cheaper Drugs Approved by FDA, but Some Aren’t ThrilledHealth
- Ozempic, Wegovy, Less Likely to Cause Suicidal Thoughts Than Other Weight Loss Drugs: NIH StudyHealth
- Costco Manager’s Phone Call to Late Employee Likely Saved Ohio Man’s LifeNews
- Bootleg Alcohol Kills 3, Injures 20Health
- Wearing Hearing Aids May Help You Live Longer: StudyHealth
- Deadly Lung Condition Can Be Slowed by This SuperfoodHealth
- Do Doctors With Addictions Have a Right to Privacy When They Seek Out Treatment?Health
